Bioharvest Sciences Inc (BHST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,135 | -12,913 | -12,564 | -11,236 | -9,827 |
| Depreciation Amortization | 1,624 | 1,251 | 840 | 712 | 389 |
| Accounts receivable | -1,105 | -594 | -22 | -588 | -266 |
| Other Working Capital | -1,942 | -555 | 755 | -308 | -96 |
| Other Operating Activity | 5,332 | 6,127 | 2,469 | 2,179 | 3,006 |
| Operating Cash Flow | $-7,226 | $-6,684 | $-8,522 | $-9,241 | $-6,794 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,355 | -2,835 | -1,474 | -1,256 | -1,640 |
| Other Investing Activity | -10 | -192 | 0 | 0 | 0 |
| Investing Cash Flow | $-2,365 | $-3,027 | $-1,474 | $-1,256 | $-1,640 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 12,402 | 3,417 | 13,517 | 7,658 | N/A |
| Debt Repayment | -5,772 | -796 | N/A | N/A | N/A |
| Common Stock Issued | 25,098 | 4,738 | 403 | 877 | 11,104 |
| Other Financing Activity | -1,541 | -579 | -364 | -397 | -332 |
| Financing Cash Flow | $30,187 | $6,780 | $13,556 | $8,138 | $10,772 |
| Exchange Rate Effect | 39 | -34 | 59 | -22 | -4 |
| Beginning Cash Position | 2,390 | 5,355 | 1,736 | 4,117 | 1,783 |
| End Cash Position | 23,025 | 2,390 | 5,355 | 1,736 | 4,117 |
| Net Cash Flow | $20,635 | $-2,965 | $3,619 | $-2,359 | $2,334 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,226 | -6,684 | -8,522 | -9,241 | -6,794 |
| Capital Expenditure | -2,355 | -2,835 | -1,474 | -1,256 | -1,640 |
| Free Cash Flow | -9,581 | -9,519 | -9,996 | -10,497 | -8,434 |